US 8273870
Compositions and methods for inhibiting expression of a mutant gene
granted A61PA61P35/00A61P35/02
Quick answer
US patent 8273870 (Compositions and methods for inhibiting expression of a mutant gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61P, A61P35/00, A61P35/02